Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.japh.2020.06.026 http://scihub22266oqcxt.onion/10.1016/j.japh.2020.06.026 32747165!7837157!32747165     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Am+Pharm+Assoc+(2003) 2020 ; 60 (6): e88-e90 Nephropedia Template TP {{tp|p=32747165|t=2020. The concern about ACE/ARB and COVID-19: Time to hold your horses!|pdf=|usr=}}{{32747165}} gab.com Text The concern about ACE/ARB and COVID-19: Time to hold your horses! JO: J Am Pharm Assoc (2003) http://www.kidney.de/pget.php?&tw=1&pmid=32747165 #FOAvip Concern about coronavirus 2019 (COVID-19) morbidity and mortality has drawn attention to the potential role of angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) because the SARS-CoV-2 uses the ACE2 receptor as its point of entry into the body. It is not clear if and to what degree the SARS-CoV-2 virus affects the renin-angoiotensin system. Early studies from China which speculated on the role of ACE inhibition and ARBs did not evaluate the drug regimens. A vast body of evidence supports the use of ACE inhibitors and ARBs in hypertensive patients and patients with heart failure, and very little evidence has been acquired about their role in COVID-19. There is good evidence in support of the use of ACE inhibitors and ARBs in indicated patients with hypertension and heart failure, and clinicians should be reticent about abruptly withdrawing these drugs based on a paucity of evidence. Twit Text FOAVip The concern about ACE/ARB and COVID-19: Time to hold your horses!????J Am Pharm Assoc (2003) http://www.kidney.de/pget.php?&tw=1&pmid=32747165 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32747165 #FOAvip English Wikipedia <ref>{{Cite pmid|32747165}}</ref> The concern about ACE/ARB and COVID-19: Time to hold your horses! #MMPMID32747165 Pergolizzi JV Jr; Varrassi G; Magnusson P; LeQuang JA; Leopoulou M; Paladini A; Taylor R; Wollmuth C; Breve F J Am Pharm Assoc (2003) 2020[Nov]; 60 (6): e88-e90 PMID32747165show ga Concern about coronavirus 2019 (COVID-19) morbidity and mortality has drawn attention to the potential role of angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) because the SARS-CoV-2 uses the ACE2 receptor as its point of entry into the body. It is not clear if and to what degree the SARS-CoV-2 virus affects the renin-angoiotensin system. Early studies from China which speculated on the role of ACE inhibition and ARBs did not evaluate the drug regimens. A vast body of evidence supports the use of ACE inhibitors and ARBs in hypertensive patients and patients with heart failure, and very little evidence has been acquired about their role in COVID-19. There is good evidence in support of the use of ACE inhibitors and ARBs in indicated patients with hypertension and heart failure, and clinicians should be reticent about abruptly withdrawing these drugs based on a paucity of evidence. |*COVID-19 Drug Treatment[MESH] |Angiotensin Receptor Antagonists/administration & dosage/*therapeutic use[MESH] |Angiotensin-Converting Enzyme 2/genetics/*metabolism[MESH] |Angiotensin-Converting Enzyme Inhibitors/administration & dosage/*therapeutic use[MESH] |Animals[MESH] |COVID-19/virology[MESH] |Heart Failure/*drug therapy/metabolism[MESH] |Humans[MESH] |Hypertension/*drug therapy/metabolism[MESH] |Renin-Angiotensin System/drug effects[MESH]The concern about ACE/ARB and COVID-19: Time to hold your horses!(epmc).pdf DeepDyve Pubget Overpricing